CANADA SIGNS DEAL TO PRODUCE NOVAVAX COVID-19 VACCINES IN MONTREAL, ONCE IT'S APPROVED
Feb 02, 2021
By Bob Komsic
Prime Minister Justin Trudeau says the government has a tentative agreement for Novavax to produce millions of doses of its COVID-19 vaccine in Canada, once it’s received approval for use here.
The American company is still doing clinical trials but if Health Canada approves, a new National Research Council facility in Montreal will start producing doses when the building’s finished later this year.
Trudeau also says the government’s also investing $25-million in Precision NanoSystems of B.C. to build a manufacturing centre, with the aim of producing up to 240-million vaccine doses per-year.
Conservative Leader Erin O’Toole welcomes the news but says such a deal should have been signed much earlier.
”Why did the Liberal government wait so long to act? when will domestically produced vaccines be available to Canadians — and how will Canadians get vaccines now?” O’Toole asks.
NDP Leader Jagmeet Singh calls the agreement a good step but very late.
”This is something that should have been secured a long time ago, it would have addressed a lot of the insecurity people are feeling about not getting the vaccine and seeing delays in the rollout because of production delays,” adds Singh.
In the meantime, Procurement Minister Anita Anand says ”all systems are a go” for shipments arriving this week; 79,000 from Pfizer and 180,400 from Moderna.